Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.
Merlini G, Lousada I, Ando Y, Dispenzieri A, Gertz MA, Grogan M, Maurer MS, Sanchorawala V, Wechalekar A, Palladini G, Comenzo RL. Merlini G, et al. Among authors: lousada i. Leukemia. 2016 Oct;30(10):1979-1986. doi: 10.1038/leu.2016.191. Epub 2016 Jul 15. Leukemia. 2016. PMID: 27416985 Free PMC article. Review.
Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group.
Maurer MS, Dunnmon P, Fontana M, Quarta CC, Prasad K, Witteles RM, Rapezzi C, Signorovitch J, Lousada I, Merlini G. Maurer MS, et al. Among authors: lousada i. Circ Heart Fail. 2022 Jun;15(6):e009038. doi: 10.1161/CIRCHEARTFAILURE.121.009038. Epub 2022 Mar 25. Circ Heart Fail. 2022. PMID: 35331001 Free PMC article. Review.
Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement.
Cheng R, Kittleson MM, Wechalekar AD, Alvarez-Cardona J, Mitchell JD, Scarlatelli Macedo AV, Dutra JPP, Campbell CM, Liu JE, Landau HJ, Davis MK, Morrissey S, Casselli S, Lousada I, Seabra-Garcez JD, Szor RS, Ganatra S, Trachtenberg B, Maurer MS, Stockerl-Goldstein K, Lenihan D. Cheng R, et al. Among authors: lousada i. Heart. 2024 May 23;110(12):823-830. doi: 10.1136/heartjnl-2023-323502. Heart. 2024. PMID: 38267197 Review.
Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group.
Mauermann ML, Clarke JO, Litchy WJ, Obici L, Lousada I, Gertz MA; Amyloidosis Forum Working Group Participants. Mauermann ML, et al. Among authors: lousada i. Adv Ther. 2023 Nov;40(11):4695-4710. doi: 10.1007/s12325-023-02637-4. Epub 2023 Sep 2. Adv Ther. 2023. PMID: 37658177 Free PMC article. Review.
The Transthyretin Amyloidosis - Quality of Life (ATTR-QOL) Questionnaire: Development of a Conceptual Model and Disease-Specific Patient-Reported Outcome Measure.
O'Connor M, Hsu K, Broderick L, McCausland KL, LaGasse K, Rebello S, Carty M, Lousada I. O'Connor M, et al. Among authors: lousada i. Patient Relat Outcome Meas. 2023 Jul 7;14:213-222. doi: 10.2147/PROM.S411721. eCollection 2023. Patient Relat Outcome Meas. 2023. PMID: 37441025 Free PMC article.
Adverse Events of Physiotherapy Interventions in Parkinsonian Patients.
Caniça V, Bouça-Machado R, Rosa MM, Ferreira JJ; CNS Physiotherapy Study Group. Caniça V, et al. Mov Disord Clin Pract. 2022 May 25;9(6):744-750. doi: 10.1002/mdc3.13466. eCollection 2022 Aug. Mov Disord Clin Pract. 2022. PMID: 35937480 Free PMC article.
19 results